Who qualifies for GLP-1 weight loss in 2026? Complete eligibility & BMI guide

Most adults qualify for GLP-1 weight loss medication with a BMI of 30 or higher, or a BMI of 27 or higher combined with at least one weight-related health condition such as high blood pressure, type 2 diabetes, or sleep apnea. That is the short answer. The fuller picture, the one that actually determines whether a licensed clinician will write your prescription, depends on your health history, current medications, and a real conversation about your goals.

At Thrive Telemedicine, our clinicians walk patients across Florida, Alabama, and Georgia through exactly that conversation, without requiring an in-person office visit. If you have tried diet and exercise for months with little lasting change and you are wondering whether semaglutide or tirzepatide could be your next step, this guide breaks down every eligibility factor a doctor actually weighs in 2026.

Key takeaways

• BMI threshold: most adults qualify for GLP-1 weight loss medication with a BMI of 30 or higher, or a BMI of 27 to 29.9 plus one weight-related condition.
• Qualifying conditions: high blood pressure, type 2 diabetes, high cholesterol, obstructive sleep apnea, and cardiovascular disease all count toward eligibility at the lower BMI threshold.
• Prescription-only medication: GLP-1 medications require a licensed clinician's evaluation. There is no legitimate way to obtain one without a real health assessment.
• Telehealth eligibility matches in-person care: licensed telehealth clinicians apply the same clinical criteria as an in-office visit, not a lower bar.
• Disqualifying factors exist: a personal or family history of medullary thyroid cancer, MEN2 syndrome, pancreatitis, or pregnancy generally rules out GLP-1 therapy.
• Semaglutide and tirzepatide share eligibility rules: medication choice usually comes down to health history and clinician judgment, not separate BMI cutoffs.
• Medical eligibility and insurance coverage are separate: qualifying clinically does not guarantee your plan will cover the medication, since costs and coverage vary widely.
• Screening is a short, structured process: intake, health history review, possible lab work, and a clinician consultation typically determine eligibility within days, not weeks.

What does GLP-1 weight loss eligibility actually mean?

GLP-1 eligibility is the set of medical criteria a licensed clinician uses to decide whether a weight loss medication such as semaglutide or tirzepatide is a safe, appropriate option for you. It is not a self-diagnosis, and it is not just a number on a chart.

Two figures start the conversation, your BMI and your health history, but a clinician also reviews your current medications, past weight loss attempts, and any condition that would make GLP-1 therapy unsafe. Our medical weight loss with GLP-1 program uses this same clinician-first process, built around a real conversation rather than a one-size-fits-all questionnaire.

What BMI do you need for GLP-1 weight loss?

Under FDA prescribing guidance for GLP-1 medications approved for weight management, most adults qualify with a BMI of 30 or higher, regardless of other health conditions. Adults with a BMI between 27 and 29.9 can also qualify, but only alongside at least one weight-related health condition.

The Centers for Disease Control and Prevention BMI categories provide the standard reference clinicians use to calculate where you fall, from healthy weight through the three classes of obesity. Think of BMI as the entry point to the conversation, not the whole conversation. A clinician still needs the full picture before recommending a plan.

BMI 30 and above: general obesity qualification

A BMI of 30 or higher places you in the obesity range on its own, which generally satisfies the eligibility bar for GLP-1 weight loss medication without needing an additional diagnosis. Clinicians will still review your full health history before prescribing, since safety screening applies regardless of BMI.

BMI 27 to 29.9: overweight with a qualifying condition

If your BMI falls between 27 and 29.9, you generally need at least one weight-related condition on top of that number, most commonly high blood pressure, type 2 diabetes, high cholesterol, or obstructive sleep apnea. This is where a documented health history matters more than the BMI figure alone. For example, an adult with a BMI of 28 and well-controlled hypertension may qualify just as readily as someone with a BMI of 33 and no other diagnosis.

What health conditions count toward GLP-1 eligibility?

For adults in the 27 to 29.9 BMI range, the qualifying condition is what unlocks eligibility. Clinicians most commonly look for:

• High blood pressure (hypertension): consistently elevated readings, treated or untreated.
• Type 2 diabetes or prediabetes: elevated blood sugar or an existing diabetes diagnosis.
• High cholesterol or other dyslipidemia: abnormal cholesterol or triglyceride levels.
• Obstructive sleep apnea: diagnosed or strongly suspected breathing interruptions during sleep.
• Cardiovascular disease: a history of heart disease, stroke, or related conditions.
• Polycystic ovary syndrome (PCOS) with metabolic features: insulin resistance or related weight-linked symptoms.

Many of these conditions also affect day-to-day energy and mood, which is part of why some patients find nutrition counseling and mental health support helpful alongside medication, not instead of it.

Semaglutide vs tirzepatide: who typically qualifies for which?

Semaglutide (the active ingredient in Wegovy and Ozempic) and tirzepatide (the active ingredient in Zepbound and Mounjaro) share the same core BMI eligibility rules. There is no separate BMI cutoff for one versus the other.

What usually drives the choice between our semaglutide weight loss program and our tirzepatide weight loss program is your health history, prior response to GLP-1 medications if any, and how your clinician weighs the two mechanisms for your specific situation.

Individual results vary, and a clinician's recommendation always takes priority over general comparisons like this one. Learn more in our full comparison of semaglutide and tirzepatide.

What disqualifies you from GLP-1 weight loss medication?

BMI and qualifying conditions open the door to eligibility, but certain factors close it regardless of your weight. Clinicians generally will not prescribe GLP-1 medication if you have:

• A personal or family history of medullary thyroid carcinoma
• A diagnosis of Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
• A history of pancreatitis
• Current pregnancy, plans to become pregnant soon, or if you are breastfeeding
• A known allergy to any ingredient in the medication
• An active, untreated eating disorder, which your clinician will want to address first

This list is not exhaustive, and only a licensed clinician reviewing your full history can confirm whether any of these apply to you. Our GLP-1 side effects and safety guide walks through what else to expect once treatment starts.

Telehealth vs in-person weight loss care: does eligibility differ?

The clinical eligibility criteria do not change based on how you meet your clinician. A telehealth visit reviews the same BMI thresholds, health history, and safety questions as an in-person appointment.

What differs is convenience, and for many of our patients across Atlanta, Savannah, Augusta, Miami, Jacksonville, Birmingham, Huntsville, and Mobile, that convenience is the difference between starting treatment and putting it off another year.

To be clear, telehealth is not a shortcut around eligibility screening. Explore our full https://thrivetelemedicine.com/contact-us/ to see how the clinician-led process works from intake through ongoing care.

How does the GLP-1 eligibility screening process work?

Most patients move through eligibility screening in four steps.

1. Complete a short online intake. You share your height, weight, and general health history, which gives your clinician a starting point before your visit.
2. A clinician reviews your BMI and history. This includes any qualifying conditions, your current medications, and prior weight loss attempts.
3. Baseline labs may be requested. Depending on your history, your clinician may ask for recent labs to confirm the medication is safe for you before prescribing.
4. You meet with a licensed clinician. This real consultation is where your questions get answered and, if appropriate, a prescription is written.

The goal is a thorough, individualized review, not a rubber stamp. Our further weight loss support page outlines what ongoing care looks like once you are approved, and our guide to how GLP-1 medications work for weight loss covers what happens after your first dose.

The bottom line on GLP-1 eligibility

Eligibility for GLP-1 weight loss medication comes down to a combination of your BMI, your health history, and a licensed clinician's judgment, not a single number. Thrive Telemedicine has built its weight loss program around that reality, pairing patients across Florida, Alabama, and Georgia with real clinicians who review your history, answer your questions, and build a plan around your specific situation rather than a generic protocol.